|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 用体外心内膜赘生物模型评价万古霉素和达托霉素对甲氧西林耐药金葡菌和异质性万古霉素中介金葡菌的抗菌活性显示文摘 | Leonard SN Rybak MJ 袁瑾懿 王明贵 | 2010 | 中国感染与化疗杂志2010，10，3： | 2 |
| 2 | Vancomy- cin therapeutic guidelines显示文摘 | Rybak MJ Lomaestro BM Rotscahfer JC | 2009 | Clin Infect Dis2009，49，3： | 1 |
| 3 | Pharmacodynamics : relation to antimicrobial re- sistance显示文摘 | Rybak MJ | 2006 | Am JMed2006，119，1： | 1 |
| 4 | The pharmacokinetic and pharmacodynamic proper- ties of vaneomyein显示文摘 | Rybak MJ | 2006 | Clin Infect Dis2006，42，1： | 1 |
| 5 | Pharmacodynamics: relalion to anlimicrobial resistance显示文摘 | Rybak MJ | 2006 | Am J Infect Control2006，1，： | 1 |
| 6 | Impact of dose de-escala- tion and escalation on daptomycin spharmacodynamics against clinical methicillirr resistant Staphylococcus aureus isolates in an in vitro model 显示文摘 | Vidaillac C Steed ME Rybak MJ | 2011 | Antimicrob Agents Chemother2011，1455，5： | 1 |
| 7 | Nephrotoxicity of vancomycin,alone and with an aminoglucoside显示文摘 | Rybak MJ Albrecht LM Boike SC | 1990 | Antimicrob Chemother1990，25，4： | 1 |
| 8 | Epidemiology,resistance,and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam显示文摘 | Jellison TK Mckinnon PS Rybak MJ | 2001 | Pharmacotherapy2001，21，： | 1 |
| 9 | The pharmacokinetic and pharmacodynamic propertiesof vancomycin显示文摘 | Rybak MJ | 2006 | Clin Infect Dis2006，42，1： | 1 |
| 10 | Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa, 显示文摘 | Rybak MJ McGrath BJ | 1996 | Antimicrob Agents Chemother1996，40，1： | 1 |
| 11 | Inhibitionof drug metabolism by quinolone antibiotics显示文摘 | Edwards DJ Bowles SK Svensson CK Rybak MJ | 1988 | Clin Pharmaco-kinet1988，15，3： | 1 |
| 12 | Nepherotoxicity of vancomycin ,alone and with an aminoglycoside显示文摘 | Albrecht LM Boike SC | 1990 | J Antimicrob Chemother1990，25，4： | 1 |
| 13 | A Review of Novel Com- binations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Muhidrug-Resistant Acinetobacter baamannii 显示文摘 | Claeys KC Fiorvento AD Rybak MJ | 2014 | Infect Dis Ther2014，3，2： | 1 |
| 14 | Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant staphylococcus aureus, vancomycin-resistant Enterococcus faecium and methicillin resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations显示文摘 | Akins RL Rybak MJ | 2001 | Antimicrob Agent Chemother2001，45，： | 1 |
| 15 | The pharmacokinetic and pharmacodynamic proper- ties of vancomycin显示文摘 | Rybak MJ | 2006 | Clin Infect Dis2006，42，1： | 1 |
| 16 | The efficacy and safety of daptomycin:first in a new class of antibiotics for gram-positive bacteria显示文摘 | Rybak MJ | 2006 | Clin Microbiol Infect2006，12，1： | 1 |
| 17 | Epidemiology, re sistanee,and outcomes of Acinetobacter baumannii bacte remia treated with imipenem-cilastatin or ampieillin-sul bactam显示文摘 | Jellison TK Mckinnon PS Rybak MJ | 2001 | Pharmaeotherapy2001，21，2： | 1 |
| 18 | In vitro activities of daptomycin, vancomycin, linezolid and quinupristin-dalfopriston against Staphylococci and Enterococci, including vancomycin-intermediate and -resistant strains显示文摘 | Rybak MJ Hershberger E Moldovan T | 2000 | Antimicrob Agents Chemother2000，44，： | 1 |
| 19 | Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity 显示文摘 | Rybak Mj Abate B J Kang SL | 1999 | Antimicrob Agents Chemother1999，43，： | 1 |
| 20 | Evaluation of daptomycin activity against Staphylococcus aureus in an in vitro pharmacodynamic model under normal and simulated impaired renal function显示文摘 | Huang V Rybak MJ | 2006 | J Antimicrob Chemother2006，57，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员